Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome

ClinicalTrials.gov ID: NCT00429364

Public ClinicalTrials.gov record NCT00429364. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 12:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Trial of Beta Blocker Therapy (Atenolol) Versus Angiotensin II Receptor Blocker Therapy (Losartan) in Individuals With Marfan Syndrome (A Trial Conducted by the Pediatric Heart Network)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Marfan syndrome is a hereditary connective tissue disorder. Many individuals with this condition die because of the associated heart and blood vessel abnormalities. This study will compare the effectiveness of two medications, losartan and atenolol, at slowing aortic root enlargement in individuals with Marfan syndrome.

Study identification

NCT ID
NCT00429364
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Carelon Research
Other
Enrollment
608 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
6 Months to 25 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2007 (Type not available)
Primary completion
Feb 2014 (Actual)
Completion
Feb 2014 (Actual)
Last update posted
Mar 7, 2025

2007 – 2014

United States locations

U.S. sites
24
U.S. states
15
U.S. cities
21
Facility City State ZIP Site status
Cedars-Sinai Medical Center Los Angeles California 90048 —
Lucile Packard Children's Hospital Palo Alto California 94304 —
Rady Children's Hospital / UCSD San Diego California 92123 —
Stanford University School of Medicine Stanford California 94305 —
Children's Memorial Hospital Chicago Illinois 60614 —
Johns Hopkins University School of Medicine Baltimore Maryland 21205 —
Children's Hospital Boston Boston Massachusetts 02115 —
Children's Hospital of Minnesota - St. Paul Saint Paul Minnesota 55102 —
Washington University School of Medicine St Louis Missouri 63110 —
Weill Medical College of Cornell University New York New York 10021 —
Mount Sinai Medical Center New York New York 10029 —
Columbia College of Physicians and Surgeons New York New York 10032 —
Duke University Medical Center Durham North Carolina 27710 —
Brody School of Medicine at East Carolina University Greenville North Carolina 27834 —
Wake Forest University Baptist Medical Center Winston-Salem North Carolina 27157 —
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 —
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 —
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15213 —
Medical University of South Carolina Charleston South Carolina 29425 —
Vanderbilt University Medical Center Nashville Tennessee 37212 —
Texas Children's Hospital Houston Texas 77030 —
Primary Children's Medical Center Salt Lake City Utah 84113 —
Seattle Children's Hospital Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00429364, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 7, 2025 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00429364 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →